| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.53 | 0.06 |